73980-25-3

Basic information

• Product Name: ethyl 4-(4-chlorophenoxy)benzoylacetate
• CAS NO: 73980-25-3
• Molecular Weight: 318.757
• Mol File: 73980-25-3.mol
• Article Data: 3

Chemical Properties

• CAS DataBase Reference: ethyl 4-(4-chlorophenoxy)benzoylacetate(CAS DataBase Reference)
• NIST Chemistry Reference: ethyl 4-(4-chlorophenoxy)benzoylacetate(73980-25-3)
• EPA Substance Registry System: ethyl 4-(4-chlorophenoxy)benzoylacetate(73980-25-3)

Safety Data

• Hazardous Substances Data: 73980-25-3(Hazardous Substances Data)

Upstream product

• 21120-67-2 4-(4'-chlorophenoxy)-benzoic acid 
• 68548-52-7 4-(4-chlorophenoxy)benzoyl chloride 
• 141-97-9 ethyl acetoacetate 
• 64-17-5 ethanol 
• 105769-20-8 4-(4-chlorophenoxy)phenyl 2,2-bis(methylthio)vinyl ketone 

Relevant articles and documents

With substituted pyrazine and imidazole derivatives, their preparation and their use in medicine (by machine translation)

The invention discloses a substituted pyrazine and imidazole derivatives, their preparation and their use in medicine. Specifically, the invention relates to a compound of general formula (I) indicated by the new derivative and its pharmaceutically acceptable salt or pharmaceutical composition containing the same, and its preparation method. The invention also discloses the derivative and its pharmaceutically acceptable salt or pharmaceutical composition containing the same in the Bruton tyrosine kinase inhibitors, and in preparing and treating and/or preventing tumor diseases such as inflammation of the application of the medicament. Wherein the general formula (I) of each substituent as defined in the specification. (by machine translation)

Studies on antihyperlipidemic agents. I. Synthesis and hypolipidemic activities of phenoxyphenyl alkanoic acid derivatives

The alkanoic acids containing phenoxyphenyl moiety at ω-position were prepared and tested for hypolipidemic property. Some of the compounds showed hypoglycemic activity besides hypolipolipidemic one. Further study on the selected compound, 3-[4-(4-chlorophenoxy)benzoyl]propionic acid (8) revealed that it increased insulin sensitivity of adipose tissue of obese and diabetic mice (KKA(y)). The structure-activity relationship was discussed briefly.